AAAAAA
Results:
1-21
|
Results: 21
Authors:
Spina, E
Avenoso, A
Facciola, G
Salemi, M
Scordo, MG
Ancione, M
Madia, AG
Perucca, E
Citation: E. Spina et al., Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia, PSYCHOPHAR, 153(2), 2001, pp. 238-243
Authors:
Cozzolino, R
Passalacqua, S
Salemi, S
Malvagna, P
Spina, E
Garozzo, D
Citation: R. Cozzolino et al., Identification of adulteration in milk by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, J MASS SPEC, 36(9), 2001, pp. 1031-1037
Authors:
Scordo, MG
Aklillu, E
Yasar, U
Dahl, ML
Spina, E
Ingelman-Sundberg, M
Citation: Mg. Scordo et al., Genetic polymorphism of cytochrome P4502C9 in a Caucasian and a black African population, BR J CL PH, 52(4), 2001, pp. 447-450
Authors:
Spina, E
Scordo, MG
Avenoso, A
Perucca, E
Citation: E. Spina et al., Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity, J CL PSYCH, 21(1), 2001, pp. 108-109
Authors:
Spina, E
Avenoso, A
Scordo, MG
Ancione, M
Madia, A
Levita, A
Citation: E. Spina et al., No effect of reboxetine on plasma concentrations of clozapine, risperidone, and their active metabolites, THER DRUG M, 23(6), 2001, pp. 675-678
Authors:
Spina, E
Avenoso, A
Facciola, G
Scordo, MG
Ancione, M
Madia, A
Citation: E. Spina et al., Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine, THER DRUG M, 23(3), 2001, pp. 223-227
Authors:
Yasui-Furukori, N
Hidestrand, M
Spina, E
Facciola, G
Scordo, MG
Tybring, G
Citation: N. Yasui-furukori et al., Different enantioselective 9-hydroxylation of risperidone by the two humanCYP2D6 and CYP3A4 enzymes, DRUG META D, 29(10), 2001, pp. 1263-1268
Authors:
Brandolese, R
Scordo, MG
Spina, E
Gusella, M
Padrini, R
Citation: R. Brandolese et al., Severe phenytoin intoxication in a subject homozygous for CYP2C93, CLIN PHARM, 70(4), 2001, pp. 391-394
Authors:
Benitez, J
Dahl, ML
Spina, E
Carrillo, JA
Citation: J. Benitez et al., Genetic and environmental factors causing variability in psychotropic drugresponse, INTERINDIVIDUAL VARIABILITY IN HUMAN DRUG METABOLISM, 2001, pp. 85-128
Authors:
Kirchheiner, J
Brosen, K
Dahl, ML
Gram, LF
Kasper, S
Roots, I
Sjoqvist, F
Spina, E
Brockmoller, J
Citation: J. Kirchheiner et al., CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages, ACT PSYC SC, 104(3), 2001, pp. 173-192
Authors:
Spina, E
Avenoso, A
Facciola, G
Scordo, MG
Ancione, M
Madia, AG
Ventimiglia, A
Perucca, E
Citation: E. Spina et al., Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics, PSYCHOPHAR, 148(1), 2000, pp. 83-89
Authors:
Avenoso, A
Facciola, G
Salemi, M
Spina, E
Citation: A. Avenoso et al., Determination of risperidone and its major metabolite 9-hydroxyrisperidonein human plasma by reversed-phase liquid chromatography with ultraviolet detection, J CHROMAT B, 746(2), 2000, pp. 173-181
Authors:
Spina, E
Cozzolino, R
Ryan, E
Garozzo, D
Citation: E. Spina et al., Sequencing of olgiosaccharides by collision-induced dissociation matrix-assisted laser desorption/ionization mass spectrometry, J MASS SPEC, 35(8), 2000, pp. 1042-1048
Authors:
Spina, E
Avenoso, A
Salemi, M
Facciola, G
Scordo, MG
Ancione, M
Madia, A
Citation: E. Spina et al., Plasma concentrations of clozapine and its major metabolites during combined treatment with paroxetine or sertraline, PHARMACOPS, 33(6), 2000, pp. 213-217
Authors:
Spina, E
Avenoso, A
Facciola, G
Salemi, M
Scordo, MG
Giacobello, T
Madia, AG
Perucca, E
Citation: E. Spina et al., Plasma concentrations of risperidone and 9-hydroxyrisperidone: Effect of comedication with carbamazepine or valproate, THER DRUG M, 22(4), 2000, pp. 481-485
Authors:
Scordo, MG
Spina, E
Romeo, P
Dahl, ML
Bertilsson, L
Johansson, I
Sjoqvist, F
Citation: Mg. Scordo et al., CYP2D6 genotype and antipsychotic-induced extrapyramidal side effects in schizophrenic patients, EUR J CL PH, 56(9-10), 2000, pp. 679-683
Authors:
Garozzo, D
Spina, E
Cozzolino, R
Cescutti, P
Fett, WF
Citation: D. Garozzo et al., Studies on the primary structure of short polysaccharides using SEC MALDI mass spectroscopy, CARBOHY RES, 323(1-4), 2000, pp. 139-146
Authors:
Scordo, MG
Spina, E
Facciola, G
Avenoso, A
Johansson, I
Dahl, ML
Citation: Mg. Scordo et al., Cytochrome P450 2D6 genotype and steady state plasma levels of risperidoneand 9-hydroxyrisperidone, PSYCHOPHAR, 147(3), 1999, pp. 300-305
Authors:
Avenoso, A
Facciola, G
Scordo, MG
Spina, E
Citation: A. Avenoso et al., No effect of the new antidepressant reboxetine on CYP2D6 activity in healthy volunteers, THER DRUG M, 21(5), 1999, pp. 577-579
Authors:
Facciola, G
Avenoso, A
Scordo, MG
Madia, AG
Ventimiglia, A
Perucca, E
Spina, E
Citation: G. Facciola et al., Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders, THER DRUG M, 21(3), 1999, pp. 341-345
Authors:
Pisani, F
Spina, E
Oteri, G
Citation: F. Pisani et al., Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice, EPILEPSIA, 40, 1999, pp. S48-S56
Risultati:
1-21
|